Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion type Assertion NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_head.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion description "[This study suggests that the CYP2C9 polymorphism may be involved in the lipid-lowering efficacy of rosuvastatin in patients with hyperlipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_provenance.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion evidence source_evidence_literature NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_provenance.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion SIO_000772 26554252 NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_provenance.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion wasDerivedFrom befree-2016 NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_provenance.
- NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_assertion wasGeneratedBy ECO_0000203 NP1295526.RAhLdU2zo-W5v62r0ek8SrMd9vP0sbSdnJiyrZpZGQ1uU130_provenance.